What happened in optometry this week: August 19 - August 23
Catch up on what happened in optometry during the week of August 19-August 23.
Catch up with what Optometry Times shared this week:
Which myopia treatment works best?
By Kate Gifford, PhD, BAppSc(Optom)Hons and Jeanne Saw, BVisSc, MOptom
There is an increasing amount of evidence demonstrating that the standard of care for children with myopia is to provide proactive myopia control treatments aimed at slowing progression. This approach moves away from single vision correction.1 This has important benefits for the patient, providing them with more stable vision with less frequent changes in refraction, as well as reducing their lifelong risk of eye disease and vision impairment that can result from increasing levels of myopia.2,3 The short-term risks of myopia control treatments, such as contact lens wear, are far outweighed by the potential long-term benefits.3,4
Study finds that COVID-19 can cause long term alterations on corneal endothelial cells
By Lynda Charters
A team of Turkish investigators lead by Oğuzhan Kılıçarslan, FEBO, FICO, MD, reported that COVID-19 affected the corneal endothelial cell morphology in patients with ocular symptoms.1 Kılıçarslan is from the Department of Ophthalmology, Ayancık State Hospital, Sinop, Turkey.
They conducted a study in which they investigated the long-term effects of the virus on corneal endothelial cell morphology in patients with ocular symptoms to assess possible corneal involvement in patients who recovered from the disease.
Visionix USA announces US launch of VX 610 fundus camera
By Jordana Joy, Associate Editor
Visionix USA has announced the launch of its VX 610 non-mydriatic automated fundus camera.1 The device features auto alignment, auto focus, and auto capture functions for retinal imaging, according to a news release.
“Our goal is to continuously advance eye care technology, enhance the patient experience, and improve the productivity of eye care professionals,” said Peter Wyles, CEO of Visionix USA, in a statement. “The VX 610 fundus camera demonstrates this commitment with its clear images, compact design, and automated capture features, ensuring precision and efficiency in screening and diagnostics.”
Efficacy of novel eye drop to reverse cataracts found in Phase 1/2 study
By Lynda Charters
Randall Olson, MD, corresponding author of the study, Moran Eye Center CEO and Distinguished Professor and Chair of the Department of Ophthalmology and Visual Sciences at the University of Utah, Salt Lake City, and colleagues reported that a novel eye drop (C-KAD, Livionex Inc.) has been formulated to treat early to moderate age-related cataracts. The drop improves vision by breaking up degraded protein complexes that cause lens clouding, which leads to cataracts and vision loss, when instilled in the eye.
How to relieve systemic dry eye before fitting new contact lenses
By Jaclyn Garlich, OD, FAAO
When patients reduce or stop wearing contact lenses due to discomfort, we should first assess the ocular surface before switching to a different lens. Today’s lenses are so advanced that, in my experience, patients’ discomfort is rarely caused by the wrong lens. It’s a symptom of dry eye disease (DED), and even mild DED can cause contact lens intolerance. Some patients are aware that DED is the problem: Nearly half of eyeglass wearers say that they’re interested in contact lenses, but 1 in 4 point to DED as the roadblock to wearing them.1
